4DMedical (4DX) AGM 2026 summary

Opening remarks and agenda

• Hybrid AGM opened after quorum confirmation; resolutions were decided by poll, with voting open during the meeting and questions welcomed in person and online.

• Twelve items covered FY26 reports, remuneration, director elections, incentive securities, share ratification, the director fee pool and constitution amendments; agenda also included addresses, formal business, Q&A and close.

Financial performance review

• FY26 revenue was $7.1m, up 121%; 344,000 scans were delivered, up 177%, across 540 sites, up 139%.

• Gross margins exceeded 90%; operating expenditure excluding non-cash share-based payments was AUD 45.7m versus AUD 45.5m in FY25.

• Cash at 30 June 2026 was $278m; $233m was raised through two placements during FY26.

• Management said higher investment could accelerate growth but shift the timing of break-even.

Board and executive committee updates

• Lil Bianchi stepped down as Chair at the close of the AGM; Julian Sutton was named incoming Chair.

• Prof Christine Jenkins, appointed 23 September 2026, stood for election; Dr Geraldine McGinty stood for re-election.

• Chris Cox was promoted from Financial Controller to CFO and Beth Plunkett from Head of Legal to General Counsel.